Breast Cancer and Immunology

Immunotherapy improves the aftereffect of clinical treatment in breast cancer patients. Targeted treatment is the approach used to directly target tumour cells, side effects of immunotherapy can be decreased.

  • Pembrolizumab (Keytruda) for breast cancer
  • PD-L1 protein

Related Conference of Breast Cancer and Immunology

October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 20-21, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Aix-en-Provence, France
February 05-06, 2026

11th World Conference on Breast and Cervical Cancer

Paris, France
February 12-13, 2026

4th World Congress on Oral Cancer

Singapore City, Singapore
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France
June 18-19, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy

Breast Cancer and Immunology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in